Literature DB >> 9951218

Neuroleptic malignant syndrome in children and adolescents.

R R Silva1, D M Munoz, M Alpert, I R Perlmutter, J Diaz.   

Abstract

OBJECTIVE: Neuroleptic malignant syndrome (NMS) is a serious iatrogenic condition. This report reviews the world literature to characterize the syndrome and evaluate factors that promote early detection and effective intervention.
METHOD: The review identified 77 NMS cases (49 males, 27 females, 1 gender unknown); ages ranged from 0.9 to 18 years (mean 14.8 +/- 3.96). Univariate and multiple regression analyses were applied to 38 variables to identify early signs of the disorder, to identify correlates of outcome, and to evaluate treatments.
RESULTS: The duration of NMS spanned from 1 to 119 days. Nine percent of patients died and 20% resolved with serious sequelae. Patients receiving low-potency neuroleptics had a poorer outcome (p = .01). Fever was related to longer duration of illness (p = .03). Anticholinergics and bromocriptine were effective and without fatalities, but dantrolene was not useful in this sample of children and adolescents.
CONCLUSIONS: Early detection and appropriate interventions appear important in moderating the course and outcome of NMS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9951218     DOI: 10.1097/00004583-199902000-00018

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  10 in total

1.  Neuroleptic malignant syndrome in a patient with citrullinaemia.

Authors:  A Dursun; Y Yilma; M Ozsari; N Kandemir; T Coşkun
Journal:  J Inherit Metab Dis       Date:  2000-12       Impact factor: 4.982

Review 2.  Management of schizophrenia in children and adolescents: focus on pharmacotherapy.

Authors:  Gabriele Masi; Francesca Liboni
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

3.  Neuroleptic Malignant Syndrome.

Authors:  N Ravishankar
Journal:  Indian J Pediatr       Date:  2015-10-08       Impact factor: 1.967

4.  Early detection of an atypical presentation of neuroleptic malignant syndrome: A case report.

Authors:  P Brittany Vickery; Lindsy Meadowcraft; Stephen B Vickery
Journal:  Ment Health Clin       Date:  2018-03-23

5.  A Complex Presentation of Pediatric Neuroleptic Malignant Syndrome Related to Polypharmacy in a 12-Year-Old Male.

Authors:  Nathaniel Sharon; Chandra Cullen; Kara Martinez
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-07-01       Impact factor: 2.576

6.  A case of neuroleptic malignant syndrome in an infant.

Authors:  Lalitha Kailas; Sheeja Sugunan; G S Bindu; Christy Cathreen Thomas
Journal:  Indian J Pediatr       Date:  2014-02-01       Impact factor: 1.967

Review 7.  Pharmacologic management of acutely agitated pediatric patients.

Authors:  Loretta Sonnier; Drew Barzman
Journal:  Paediatr Drugs       Date:  2011-02-01       Impact factor: 3.022

Review 8.  Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review.

Authors:  Rachel Neuhut; Jean-Pierre Lindenmayer; Raul Silva
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-08       Impact factor: 2.576

Review 9.  Managing an effective treatment for neuroleptic malignant syndrome.

Authors:  Udo Reulbach; Carmen Dütsch; Teresa Biermann; Wolfgang Sperling; Norbert Thuerauf; Johannes Kornhuber; Stefan Bleich
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 10.  A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review.

Authors:  Yu-Jie Chiou; Yu Lee; Chin-Chuen Lin; Tiao-Lai Huang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.